Instituto di Ematologia ed Oncologia Medica

Bologna 40138

0 studies enrolling now · 4 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Disease, Hodgkin, Lymphoma, B-cell, Lymphoma, Large B-cell, Diffuse, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early
• A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma — Completed